Bone morphogenetic protein receptor type-1A

Description:

Description
  • Accession: P36894
  • Swissprot: BMR1A_HUMAN
  • Organism: Homo sapiens
  • Gene: BMPR1A
  • Target class: Kinase

Drug Relations:

dasatinib
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. Bioactivity details MOA